out-of-pocket costpatient costtime costBackgroundHepatitis C virus (HCV) infection is associated with substantial costs to patients, their caregivers and society.AimsWe evaluated time costs (time spent seeking healthcare) and out-of-pocket (OOP) costs for patients with HCV and their caregivers....
Patient cost-sharing for medical services is determined by specific benefit design features; these costs often vary throughout the year depending on when patients meet deductibles and out-of-pocket (OOP) maximums. In addition, reimbursement rates negotiated between insurers and hospitals or clinics ...
This cohort study examines the association of reaching age 65 years and enrolling in Medicare with out-of-pocket costs and utilization of type 2 diabetes
The research firm said key patient engagement efforts, like chronic disease management, will be essential for capping growing out-of-pocket spending. Additionally, referring patients to low-cost healthcare options, like generic drugs and different types of health plans, will be key...
Out-of-pocket costs worry patients It's not just coverage for services that worry patients; it's the out-of-pocket healthcare costs they'll incur for those services, too. In fact, patients are just as worried about affording their medical bills as they are worried about affordi...
RESULTS. Overall, 248 cannabis users provided data on cost and were analyzed. Median monthly out-of-pocket cost for cannabis was $80 (interquartile range = $25-$150). On regression analysis, male gender (odds ratio = 2.5, 95% confidence interval = 1.2 to 5.5, P = .026) and being ...
Background Out-of-pocket (OOP) costs can be substantial financial burdens for patients and may even cause patients to delay or forgo necessary medical procedures. Although overall healthcare costs are rising in the United States, recent trends in patient OOP costs for foot and ankle orthopaedic ...
including a closer look into PBM practices. The researchers believe that these findings point to entecavir as an examplemedicationthat could be ripe for market disruption, to the benefit of patients. A large decrease in the out-of-pocket cost for entecavir is feasible but will require new approa...
Out-of-pocket payments differ widely among oral oncolytic options. As cost for therapy becomes a greater part of treatment decisions, an understanding of patient out-of-pocket cost will be critical in informing choices. This article was published as part of a special joint issue a...
including launching low-list-price, non-branded insulins in 2019, implementing theLillyInsulin Value Program in 2020 and committing all of our insulins to the Medicare Part D Senior Savings Model in 2021. Because of these efforts, the average out-of-pocket cost forLi...